{"id":6500,"date":"2013-05-20T06:14:30","date_gmt":"2013-05-20T10:14:30","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=6500"},"modified":"2013-05-20T06:14:45","modified_gmt":"2013-05-20T10:14:45","slug":"prima-biomed-ltd-nasdaqpbmd-down-by-15-47","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500","title":{"rendered":"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47%"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/20\/2013 (wallstreetpr) &#8211; Friday\u2019s trading session saw Prima Biomed Ltd (NASDAQ:PBMD) climbing down by 15.47%. It opened at a price of $2.62 which was also the intraday high, before heading down to close at $1.70 per share. In excess of 0.195 million shares exchanged hands in the previous trading session. This figure stood below the average volume of 0.467 million that was measured over a 30-day period.<\/p>\n<p style=\"text-align: justify;\">PBMD has announced that in pursuant to shareholder approval that was received at general meeting held last weekend that its has issued 13,287,500 fully-paid ordinary shares to its directors as well as 1,250,000 shares to some of its\u00a0 institutional investors. These have been issued on the same terms and price as the Share purchase plan that was recently completed. The issue price of the new shares under the SPP was calculated as the volume weighted average-price of existing shares. These were traded on ASX over the 10 trading days before their issue date minus a discount of 5% and amounted to $0.08 per Share.<\/p>\n<p style=\"text-align: justify;\">The proceeds from this SPP and the added placements that were passed at the general meeting amounted to $6,166,676. Prima Biomed Ltd (NASDAQ:PBMD) may seek to place additional shares on these same terms as that of the SPP, to professional investors within the next quarter.<br \/>\nThese proceeds will enable PBMD to co-fund up to three phase II trials of CVac(TM). These will be for additional cancer indications and will be conducted in conjunction with the grant of EUR 3.8 million that was recently awarded by the Germany-based Saxony Development Bank.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/20\/2013 (wallstreetpr) &#8211; Friday\u2019s trading session saw Prima Biomed Ltd (NASDAQ:PBMD) climbing down by 15.47%. It opened at a price of $2.62 which [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":6501,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2160,2159],"stock_ticker":[],"class_list":["post-6500","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqpbmd","tag-prima-biomed-ltd-nasdaqpbmd","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47% - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47% - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/20\/2013 (wallstreetpr) &#8211; Friday\u2019s trading session saw Prima Biomed Ltd (NASDAQ:PBMD) climbing down by 15.47%. It opened at a price of $2.62 which [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-05-20T10:14:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-05-20T10:14:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Brendan Byrne\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brendan Byrne\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500\"},\"author\":{\"name\":\"Brendan Byrne\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511\"},\"headline\":\"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47%\",\"datePublished\":\"2013-05-20T10:14:30+00:00\",\"dateModified\":\"2013-05-20T10:14:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500\"},\"wordCount\":261,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg\",\"keywords\":[\"NASDAQ:PBMD\",\"Prima Biomed Ltd (NASDAQ:PBMD)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500\",\"name\":\"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47% - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg\",\"datePublished\":\"2013-05-20T10:14:30+00:00\",\"dateModified\":\"2013-05-20T10:14:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511\",\"name\":\"Brendan Byrne\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g\",\"caption\":\"Brendan Byrne\"},\"description\":\"While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/u\/0\/116608759701551457422).\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/brendan-byrne\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47% - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500","og_locale":"en_US","og_type":"article","og_title":"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47% - Wall Street PR","og_description":"Boston, MA 05\/20\/2013 (wallstreetpr) &#8211; Friday\u2019s trading session saw Prima Biomed Ltd (NASDAQ:PBMD) climbing down by 15.47%. It opened at a price of $2.62 which [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-05-20T10:14:30+00:00","article_modified_time":"2013-05-20T10:14:45+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg","type":"image\/jpeg"}],"author":"Brendan Byrne","twitter_misc":{"Written by":"Brendan Byrne","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500"},"author":{"name":"Brendan Byrne","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511"},"headline":"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47%","datePublished":"2013-05-20T10:14:30+00:00","dateModified":"2013-05-20T10:14:45+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500"},"wordCount":261,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg","keywords":["NASDAQ:PBMD","Prima Biomed Ltd (NASDAQ:PBMD)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500","url":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500","name":"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47% - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg","datePublished":"2013-05-20T10:14:30+00:00","dateModified":"2013-05-20T10:14:45+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/Wall_Street_Sign.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/prima-biomed-ltd-nasdaqpbmd-down-by-15-47-6500#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Prima Biomed Ltd (NASDAQ:PBMD) down by 15.47%"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/63a75bf2d685d9d351a6f01cfc69b511","name":"Brendan Byrne","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c07a17b7438044417a1ad0f7933a311fcc2a96eaf4b15f2599b0fdfb37cbda41?s=96&d=mm&r=g","caption":"Brendan Byrne"},"description":"While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email (brendanbyrne@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/u\/0\/116608759701551457422).","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/brendan-byrne"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/6500","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=6500"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/6500\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/6501"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=6500"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=6500"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=6500"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=6500"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}